Monografie
Biphasic relation between liver stiffness and liver iron in patients with alcoholic liver disease
- Sprache
-
Englisch
- Umfang
-
i, 53 Blätter
- Identifier
-
1220363243
Thema
Hochschulschrift
Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Der Zugriff auf Teile des Objekts ist unbeschränkt möglich.
- Letzte Aktualisierung
-
16.08.2023, 18:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
Ähnliche Objekte (12)
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging
Dietary wheat amylase trypsin inhibitors worsen chronic liver disease in preclinical models of non-alcoholic fatty liver disease and liver fibrosis
Mechanisms of carcinogenic iron accumulation in alcoholic liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
H2O2-mediated autophagy during ethanol metabolism in alcoholic liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Immunology and liver disease
Lipoproteins in Liver Disease
Integration of Clinical Examination, Self-Report, and Hair Ethyl Glucuronide Analysis for Evaluation of Patients With Alcoholic Liver Disease Prior to Liver Transplantation
Progressive liver disease in patients with ataxia telangiectasia
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging
Dietary wheat amylase trypsin inhibitors worsen chronic liver disease in preclinical models of non-alcoholic fatty liver disease and liver fibrosis
Mechanisms of carcinogenic iron accumulation in alcoholic liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
H2O2-mediated autophagy during ethanol metabolism in alcoholic liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Immunology and liver disease
Lipoproteins in Liver Disease
Integration of Clinical Examination, Self-Report, and Hair Ethyl Glucuronide Analysis for Evaluation of Patients With Alcoholic Liver Disease Prior to Liver Transplantation
Progressive liver disease in patients with ataxia telangiectasia
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging
Dietary wheat amylase trypsin inhibitors worsen chronic liver disease in preclinical models of non-alcoholic fatty liver disease and liver fibrosis
Mechanisms of carcinogenic iron accumulation in alcoholic liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
H2O2-mediated autophagy during ethanol metabolism in alcoholic liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Immunology and liver disease
Lipoproteins in Liver Disease
Integration of Clinical Examination, Self-Report, and Hair Ethyl Glucuronide Analysis for Evaluation of Patients With Alcoholic Liver Disease Prior to Liver Transplantation